Genetic vaccination-induced immune responses to the human immunodeficiency virus protein Rev: Emergence of the interleukin 2-producing helper T lymphocyte

Human Gene Therapy

Volumn 9, Issue 15, 1998, Pages 2187-2196

  Chan, Sherri Y ^a   Louie, Marisa C ^a   Piccotti, Joseph R ^a   Iyer, Gaitry ^a   Ling, Xu ^b   Yang, Zhi Yong ^b   Nabel, Gary J ^a,b   Bishop, D Keith ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2; REV PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA TRANSFECTION; FEMALE; GENE THERAPY; GENE TRANSFER; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; KINETICS; MOUSE; NONHUMAN; PLASMID; SPLEEN CELL; VIRUS IMMUNITY;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0032505746     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.15-2187     Document Type: Article

References (8)

1. BAHNER, I., ZHOU, C, YU, X.-J., HAO, Q.-L., GUATELLI, J.C., and KOHN, D.B. (1993). Comparison of trans-dominant inhibitor mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes. J. Virol. 67, 3199-3207.
2. BEVEC, D., DOBROVNIK, M., HAUBER, J., and BOHNLEIN, E. (1992). Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator. Proc. Natl. Acad. Sci. U.S.A. 89, 9870-9874.
3. BISHOP, D.K., and OROSZ, C.G. (1989). Limiting dilution analysis for allo-reactive, TCGF-secreting T cells: LDA methods that discriminate between unstimulated precursor T cells and in vivo alloactivated T cells. Transplantation 47, 671-677.
4. BISHOP, D.K., FERGUSON, R.M., and OROSZ, C.G. (1992). Differential distribution of antigen specific helper T cells and cytotoxic T cells following antigenic stimulation in vivo: A functional study using limiting dilution analysis. J. Immunol. 144, 1153-1160.
5. - SCID: Initial trial results after 4 years. Science 270, 475-480.
6. BLAZEVIC, V., RANKI, A., and KROHN, K.J.E. (1995). Helper and cytotoxic T cell responses of HIV type 1-infected individuals to synthetic peptides of HIV type 1 Rev. AIDS Res. Hum. Retroviruses 11, 1335-1342.
7. BORDER, W.A., and RUOSLAHTI, E. (1992). Transforming growth factor-β in disease: The dark side of tissue repair. J. Clin. Invest. 90, 1.
8. BRACIALE, T.J., and BRACIALE, V.L. (1991). Antigen presentation: Structural themes and functional variations. Immunol. Today 12, 124-129.